The iconic rise of Viagra has consistently remained a example of pharmaceutical success, but its legacy within the broader sector now raises questions about future returns . Alternative versions are eroding market share, causing worries that betting on companies heavily reliant to Viagra's once-dominant influence could be a problematic move , espec